AstraZeneca AB et al v. Torrent Pharmaceuticals Ltd. et al
AstraZeneca AB and AstraZeneca Pharmaceuticals LP |
Torrent Pharmaceuticals Ltd. and Torrent Pharma Inc. |
1:2021cv01116 |
July 30, 2021 |
US District Court for the District of Delaware |
Richard G Andrews |
Patent - Abbreviated New Drug Application(ANDA) |
35 U.S.C. ยง 271 |
None |
Docket Report
This docket was last retrieved on September 21, 2021. A more recent docket listing may be available from PACER.
Document Text |
---|
SO ORDERED, re #11 Stipulation and Proposed Order to Extend Time (*Reset Answer Deadlines: Torrent Pharma Inc. answer due 10/22/2021; Torrent Pharmaceuticals Ltd. answer due 10/22/2021). Signed by Judge Richard G. Andrews on 9/21/2021. (nms) |
Filing 11 STIPULATION and [Proposed] Order to Extend Time, by Torrent Pharma Inc., Torrent Pharmaceuticals Ltd.. (Kirby, April) Modified on 9/21/2021 (nms). |
SO ORDERED, re #10 STIPULATION and Proposed Order to Extend Time (*Reset Answer Deadlines: Torrent Pharma Inc. answer due 9/22/2021; Torrent Pharmaceuticals Ltd. answer due 9/22/2021). Signed by Judge Richard G. Andrews on 8/9/2021. (nms) |
Filing 10 STIPULATION TO EXTEND TIME for Defendants to Answer, Move, or Otherwise Respond to Complaint to September 22, 2021 - filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP. (Joyce, Alexandra) |
Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (rjb) |
Filing 9 AFFIDAVIT of Service for Complaint and Ancillary Pleadings served on Torrent Pharmaceuticals Ltd. on August 2, 2021, filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP. (Attachments: #1 Exhibit A-B)(Joyce, Alexandra) |
Filing 8 SUMMONS Returned Executed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP. Torrent Pharma Inc. served on 8/2/2021, answer due 8/23/2021. (Joyce, Alexandra) |
Filing 7 Summons Issued with Magistrate Consent Notice attached as to Torrent Pharma Inc. on 7/30/2021; Torrent Pharmaceuticals Ltd. on 7/30/2021. (Attachments: #1 Summons Issued)(apk) |
Filing 6 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent AstraZeneca PLC for AstraZeneca Pharmaceuticals LP filed by AstraZeneca Pharmaceuticals LP. (apk) |
Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent AstraZeneca PLC for AstraZeneca AB filed by AstraZeneca AB. (apk) |
Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,300,065. (apk) |
Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 06/17/2021. Date of Expiration of Patent: 01/27/2036.Thirty Month Stay Deadline: 12/17/2023. (apk) |
Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (apk) |
Filing 1 COMPLAINT FOR PATENT INFRINGEMENT filed against Torrent Pharma Inc., Torrent Pharmaceuticals Ltd. - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3669460.) - filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP. (Attachments: #1 Exhibit A, #2 Civil Cover Sheet)(apk) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.